Alebund Pharmaceutical announced the 1st closing of RMB 550 million in Series C financing
SHANGHAI and YANGZHOU,China,Jan. 7,2025--Alebund Pharmaceuticals ("Alebund" or the "Company"),an integrated biopharmaceutical company focusing on developing innovative therapies fo